Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Keith Stewart

Showing results (21-30 of 215) with videos related to

Pageof 22
Sort By:
British Journal of Haematology|October 20, 2004
Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletionsHong Chang, Stephen Sloan, Dan Li, et al.
Acta Biochimica Et Biophysica Sinica|December 31, 2013
Mechanism of immunomodulatory drugs' action in the treatment of multiple myelomaXiubao Chang, Yuanxiao Zhu, Changxin Shi, et al.
Leukemia & Lymphoma|September 13, 2012
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myelomaYuan Xiao Zhu, K Martin Kortuem, A Keith Stewart
Current Hematology Reports|December 30, 2003
Insights from the gene expression profiling of multiple myelomaJaime O Claudio, Esther Masih-Khan, A Keith Stewart
Blood|October 29, 2009
How I treat multiple myeloma in younger patientsA Keith Stewart, Paul G Richardson, Jesus F San-Miguel
Annals of Hematology|October 27, 2004
IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantationAshutosh Wechalekar, Dominic Amato, Chris Chen, et al.
Leukemia & Lymphoma|May 10, 2002
Antigenic open reading frames from HHV-8 are present in multiple myeloma patients and normal individuals at similar frequencyYuan Xiao Zhu, Zhi Hua Li, Michael Voralia, et al.
Journal of Human Genetics|November 19, 2002
Polymorphisms in the gene encoding phosphatidylserine-specific phospholipase A1 ( PSPLA1)Jian Wang, Xiao-Yan Wen, A Keith Stewart, et al.
Blood|September 2, 2004
p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantationHong Chang, Connie Qi, Qi-Long Yi, et al.
Blood|October 24, 2002
Overexpression of the myeloma-associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistanceJonathan B Pollett, Suzanne Trudel, Daniel Stern, et al.
Pageof 22

Showing results (21-30 of 215) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|October 20, 2004
Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletionsHong Chang, Stephen Sloan, Dan Li, et al.
Acta Biochimica Et Biophysica Sinica|December 31, 2013
Mechanism of immunomodulatory drugs' action in the treatment of multiple myelomaXiubao Chang, Yuanxiao Zhu, Changxin Shi, et al.
Leukemia & Lymphoma|September 13, 2012
Molecular mechanism of action of immune-modulatory drugs thalidomide, lenalidomide and pomalidomide in multiple myelomaYuan Xiao Zhu, K Martin Kortuem, A Keith Stewart
Current Hematology Reports|December 30, 2003
Insights from the gene expression profiling of multiple myelomaJaime O Claudio, Esther Masih-Khan, A Keith Stewart
Blood|October 29, 2009
How I treat multiple myeloma in younger patientsA Keith Stewart, Paul G Richardson, Jesus F San-Miguel
Annals of Hematology|October 27, 2004
IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantationAshutosh Wechalekar, Dominic Amato, Chris Chen, et al.
Leukemia & Lymphoma|May 10, 2002
Antigenic open reading frames from HHV-8 are present in multiple myeloma patients and normal individuals at similar frequencyYuan Xiao Zhu, Zhi Hua Li, Michael Voralia, et al.
Journal of Human Genetics|November 19, 2002
Polymorphisms in the gene encoding phosphatidylserine-specific phospholipase A1 ( PSPLA1)Jian Wang, Xiao-Yan Wen, A Keith Stewart, et al.
Blood|September 2, 2004
p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantationHong Chang, Connie Qi, Qi-Long Yi, et al.
Blood|October 24, 2002
Overexpression of the myeloma-associated oncogene fibroblast growth factor receptor 3 confers dexamethasone resistanceJonathan B Pollett, Suzanne Trudel, Daniel Stern, et al.
Pageof 22